Chinese University of Hong Kong
Inex Innovate to Launch PCR-Based Endometrial Cancer Detection Test
The Singapore-based company plans to launch the epiHera test in August, following interim results from a clinical study with researchers at the Chinese University of Hong Kong.
The test relies on a spermine risk score coupled with a urine test to predict which patients are most likely to have prostate cancer.
Prenetics, Prudential, CUHK, Others Partner to Increase COVID-19 Test Access in Hong Kong
The Project Screen initiative aims to provide the Hong Kong community with home access to the World Health Organization-approved RT-PCR test for SARS-CoV-2 at zero profit to its organizers.
Hong Kong's Take2 to Commercialize Early Cancer Detection Test; Focus on Healthcare Informatics
Premium
Take2 Health plans to launch an nasopharyngeal carcinoma early detection test in the next several months in Hong Kong and southern China.
Hong Kong Startup Licenses Nasopharyngeal Cancer Early Detection Technology From Grail
Take2 was founded by Chinese University of Hong Kong researchers and will commercialize a cell-free DNA test for early cancer detection.